Background
==========

Malaria is one of the world's public health problems in terms of medical emergency with a high risk of mortality. The protozoan malaria parasites are transmitted by infected female mosquitoes \[[@B1]\]. The most pathogenic human malaria parasite, *Plasmodium falciparum*, has gradually expanded in last three decades \[[@B2]\]. Choloroquine is the cheapest and the most widely used drug in almost endemic countries. However, *Plasmodium falciparum* exhibits resistance to their drug. Resistance to the combination of sulfadoxine-pyrimethamine was also already emerged \[[@B3]\]. Farnesyltransferase have been identified in eukaryotic organisms, including pathgenic protozoa of the genera Plasmodium \[[@B3],[@B4]\]. Therefore, the inhibition of farnesyltransferase has been suggested as a new strategy for the malaria treatment. However, the exact mechanism of action of this class of agents is still unknown \[[@B5]\]. In addition, the effect of farnesyltransferase inhibitor on malaria mitochondria level is not fully understood. In this study, the effect of farnesyltransferase inhibitor on the function of mitochondria of *Plasmodium falciparum* were investigated experimentally. The oxygen distribution and the morphological shape of farnesyltransferase inhibitor-treated mitochondria were examined under *in vitro* condition. From this study, we found farnesyltransferase inhibitor is very important to understand the mitochondrial function of *Plasmodium falciparum* as an antimalarial drug.

Materials and methods
=====================

Culture of malaria parasites.

Synchronization of *Plasmodium falciparum*.

Determination of oxygen gradients in malaria.

Results
=======

In this study, farnesyltransferase inhibitor was treated to RBCs (Red blood cells) uninfected by *Plasmodium falciparum.* Farnesyltransferase inhibitor has noticeable effects on mitochondrial function of malaria parasites, compared to the control case for non-infected RBCs.

Conclusion
==========

Oxygen distribution and morphological shape of farnesyltransferase inhibitor-treated mitochondria were investigated under *in vitro* condition. The farnesyltransferase inhibitor was observed to be very important to understand the mitochondrial function of malaria parasite as an effective antimalarial drug.
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